Winnie Thabisa Ramaloko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Winnie Thabisa Ramaloko has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Sinethemba Hopewell Yakobi
Patho-Biocatalysis Group (PBG), Department of Biotechnology and Biological Sciences, University of Fort Hare, Private Bag X1314, Alice 5700, South Africa
3 shared publications - John Osei Sekyere
Department of Medical Microbiology, School of Medicine University of Pretoria Pretoria South Africa
2 shared publications - Nontuthuko Excellent Maningi
Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
2 shared publications Karabelo M Moloantoa
1 shared publicationMatthew A Adeleke
1 shared publication- Matthew Adekunle Adeleke
University of KwaZulu-Natal
1 shared publication
Latest Publications
- Open Access
- 20 January 2026
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 2
Network-guided functional enrichment and interface-focused prioritization of quorum sensing targets in Pseudomonas aeruginosa for anti-virulence drug discovery
- 20 January 2026
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 2
Open AccessNetwork-guided functional enrichment and interface-focused prioritization of quorum sensing targets in Pseudomonas aeruginosa for anti-virulence drug discovery
- Open Access
- 1 January 2026
- Published by AOSIS in Southern African Journal of Infectious Diseases
- Vol. 41 (1) , 10
A bibliometric analysis of the literature on Mycoplasma and Ureaplasma infections
Background: Mycoplasma and Ureaplasma species are understudied opportunistic pathogens that infect humans, animals and plants. These infections are often asymptomatic, which, together with fastidious growth requirements, makes them challenging to detect. Aim: The review aimed to provide a bibliometric analysis of available literature to reflect and assess trends, progress and knowledge gaps in this field. Setting: This article is a literature review. Method: A bibliometric analysis of 19 486 documents from 1992 to 2022 was conducted using the Web of Science database and in-depth analyses on RStudio. Results: China and the United States produced a high number of publications and citations. South Africa, the first most-cited African country, contributed 685 publications, ranking 24th globally with 2031 citations. Veterinary Microbiology was the highest performing journal with 448 papers and 10 036 citations. The most frequent keywords were ‘infection’ and ‘Ureaplasma urealyticum’. Conclusion: Research on Mycoplasma and Ureaplasma infections has progressed over time, but mainly in developed countries. The restricted publications and moderate citations in South Africa suggest research gaps in understanding the true burden and impacts of these infections. Contribution: This study provides a comprehensive bibliometric overview of Mycoplasma and Ureaplasma infections and reports the global and local progress in this field. The overall moderate, steady growth highlights the need for broader international collaboration and expanded research efforts in low-resource countries to address existing research gaps. This expansion is essential, particularly in clinical research, for strengthening both surveillance and treatment guidelines.
- 1 January 2026
- Published by AOSIS in Southern African Journal of Infectious Diseases
- Vol. 41 (1) , 10
Open AccessA bibliometric analysis of the literature on Mycoplasma and Ureaplasma infections
Background: Mycoplasma and Ureaplasma species are understudied opportunistic pathogens that infect humans, animals and plants. These infections are often asymptomatic, which, together with fastidious growth requirements, makes them challenging to detect. Aim: The review aimed to provide a bibliometric analysis of available literature to reflect and assess trends, progress and knowledge gaps in this field. Setting: This article is a literature review. Method: A bibliometric analysis of 19 486 documents from 1992 to 2022 was conducted using the Web of Science database and in-depth analyses on RStudio. Results: China and the United States produced a high number of publications and citations. South Africa, the first most-cited African country, contributed 685 publications, ranking 24th globally with 2031 citations. Veterinary Microbiology was the highest performing journal with 448 papers and 10 036 citations. The most frequent keywords were ‘infection’ and ‘Ureaplasma urealyticum’. Conclusion: Research on Mycoplasma and Ureaplasma infections has progressed over time, but mainly in developed countries. The restricted publications and moderate citations in South Africa suggest research gaps in understanding the true burden and impacts of these infections. Contribution: This study provides a comprehensive bibliometric overview of Mycoplasma and Ureaplasma infections and reports the global and local progress in this field. The overall moderate, steady growth highlights the need for broader international collaboration and expanded research efforts in low-resource countries to address existing research gaps. This expansion is essential, particularly in clinical research, for strengthening both surveillance and treatment guidelines.
- Open Access
- 1 July 2025
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 43, 102124
Molecular characterization and inhibition of cyclic-di-GMP receptor proteins in Pseudomonas aeruginosa: INSIGHTS from docking and dynamics studies
- 1 July 2025
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 43, 102124
Open AccessMolecular characterization and inhibition of cyclic-di-GMP receptor proteins in Pseudomonas aeruginosa: INSIGHTS from docking and dynamics studies
- Open Access
Phylogenomics, Epigenomics, Virulome, and Mobilome of Gram-negative Bacteria Co-resistant to Carbapenems and Polymyxins: A One-Health Systematic Review and Meta-analyses
Gram-negative bacteria (GNB) continue to develop resistance against important antibiotics including last-resort ones such as carbapenems and polymyxins. An analysis of GNB with co-resistance to carbapenems and polymyxins from a One Health perspective is presented. Data of species name, country, source of isolation, resistance genes (ARGs), plasmid type, clones, and mobile genetic elements (MGEs) were deduced from 129 articles from January 2016 to March 2021. Available genomes and plasmids were obtained from PATRIC and NCBI. Resistomes and methylomes were analysed using BAcWGSTdb and REBASE whilst Kaptive was used to predict capsule typing. Plasmids and other MEGs were identified using MGE Finder and ResFinder. Phylogenetic analyses were done using RAxML and annotated with MEGA 7. A total of 877 isolates, 32 genomes and 44 plasmid sequences were analysed. Most of these isolates were reported in Asian countries and were isolated from clinical, animal, and environmental sources. Colistin resistance was mostly mediated by mgrB inactivation, while OXA-48/181 was the most reported carbapenemase. IncX and IncI were the most common plasmids hosting carbapenemases and mcr genes. The isolates were co-resistant to other antibiotics, with floR (chloramphenicol) and fosA3 (fosfomycin) being common; E. coli ST156 and K. pneumoniae ST258 strains were common globally. Virulence genes and capsular KL-types were also detected. Type I, II, III and IV restriction modification systems were detected, comprising various MTases and restriction enzymes. The escalation of highly resistant isolates drains the economy due to untreatable bacterial infections, which leads to increasing global mortality rates and healthcare costs. Author summary: Carbapenem and polymyxin co-resistance in Gram-negative bacteria (GNB) is a growing public health concern globally. China presented a high number of highly resistant bacteria from humans, animals, and environmental samples. Escherichia coli isolates were the most dominant in China, while Klebsiella pneumoniae isolates dominated Greece, the second country with high numbers of carbapenem and colistin co-resistant strains. Mobile genetic elements including plasmids are responsible for disseminating such resistance genes. Worryingly, GNB with Carbapenem and polymyxin co-resistance also harbours genes that make them resistant to other antibiotics, making them multi-drug resistant.
Open AccessPhylogenomics, Epigenomics, Virulome, and Mobilome of Gram-negative Bacteria Co-resistant to Carbapenems and Polymyxins: A One-Health Systematic Review and Meta-analyses
Gram-negative bacteria (GNB) continue to develop resistance against important antibiotics including last-resort ones such as carbapenems and polymyxins. An analysis of GNB with co-resistance to carbapenems and polymyxins from a One Health perspective is presented. Data of species name, country, source of isolation, resistance genes (ARGs), plasmid type, clones, and mobile genetic elements (MGEs) were deduced from 129 articles from January 2016 to March 2021. Available genomes and plasmids were obtained from PATRIC and NCBI. Resistomes and methylomes were analysed using BAcWGSTdb and REBASE whilst Kaptive was used to predict capsule typing. Plasmids and other MEGs were identified using MGE Finder and ResFinder. Phylogenetic analyses were done using RAxML and annotated with MEGA 7. A total of 877 isolates, 32 genomes and 44 plasmid sequences were analysed. Most of these isolates were reported in Asian countries and were isolated from clinical, animal, and environmental sources. Colistin resistance was mostly mediated by mgrB inactivation, while OXA-48/181 was the most reported carbapenemase. IncX and IncI were the most common plasmids hosting carbapenemases and mcr genes. The isolates were co-resistant to other antibiotics, with floR (chloramphenicol) and fosA3 (fosfomycin) being common; E. coli ST156 and K. pneumoniae ST258 strains were common globally. Virulence genes and capsular KL-types were also detected. Type I, II, III and IV restriction modification systems were detected, comprising various MTases and restriction enzymes. The escalation of highly resistant isolates drains the economy due to untreatable bacterial infections, which leads to increasing global mortality rates and healthcare costs. Author summary: Carbapenem and polymyxin co-resistance in Gram-negative bacteria (GNB) is a growing public health concern globally. China presented a high number of highly resistant bacteria from humans, animals, and environmental samples. Escherichia coli isolates were the most dominant in China, while Klebsiella pneumoniae isolates dominated Greece, the second country with high numbers of carbapenem and colistin co-resistant strains. Mobile genetic elements including plasmids are responsible for disseminating such resistance genes. Worryingly, GNB with Carbapenem and polymyxin co-resistance also harbours genes that make them resistant to other antibiotics, making them multi-drug resistant.